phtaloyl-glycyl-N-methylamid | 42472-84-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: phtaloyl-glycyl-N-methylamid
• 英文别名: 2-(1,3-dioxoisoindolin-2-yl)-N-methylacetamide；2-Isoindolineacetamide, 1,3-dioxo-N-methyl-；2-(1,3-dioxoisoindol-2-yl)-N-methylacetamide
• CAS: 42472-84-4
• 化学式: C₁₁H₁₀N₂O₃
• mdl: MFCD00708273
• 分子量: 218.212
• InChiKey: DNXINDLAKLTTSK-UHFFFAOYSA-N

物化性质

• 熔点：
  252 °C(Solv: methanol (67-56-1))
• 沸点：
  449.1±28.0 °C(Predicted)
• 密度：
  1.342±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.181
• 拓扑面积：
  66.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  phtaloyl-glycyl-N-methylamid 在 sodium azide 、 三氯氧磷 作用下， 以 乙腈 为溶剂， 以89%的产率得到2-[(1-methyl-1H-tetrazol-5-yl)methyl]isoindoline-1,3-dione
  参考文献：
  名称：

  方便的一锅合成含有氨基或羧基的1,5-二取代的四唑

  摘要：

  摘要提出了一种方便的方法，该方法是通过酰胺与三氯氧化磷和叠氮化钠的一锅反应来构建四唑环。获得了一系列含有氨基或羧基的1，5-二取代的四唑，其作为合成生物活性物质的基础材料而受到关注。

  DOI：

  10.1134/s1070428020050127
• 作为产物：
  描述：

  邻苯二甲酰甘氨酸 在 氯化亚砜 作用下， 以 1,4-二氧六环 、 水 为溶剂， 反应 2.5h， 生成 phtaloyl-glycyl-N-methylamid
  参考文献：
  名称：

  方便的一锅合成含有氨基或羧基的1,5-二取代的四唑

  摘要：

  摘要提出了一种方便的方法，该方法是通过酰胺与三氯氧化磷和叠氮化钠的一锅反应来构建四唑环。获得了一系列含有氨基或羧基的1，5-二取代的四唑，其作为合成生物活性物质的基础材料而受到关注。

  DOI：

  10.1134/s1070428020050127

文献信息

• Photodecarboxylative additions of N-protected α-amino acids to N-methylphthalimide
  作者：Sonia Gallagher、Fadi Hatoum、Nicolai Zientek、Michael Oelgemöller

  DOI：10.1016/j.tetlet.2010.05.020

  日期：2010.7

  Photoreactions involving N,N-dimethylated α-amino acid salts and N-methylphthalimide are dominated by photoreduction and acetone trapping. Only, N-phenyl glycinate underwent photodecarboxylative addition in a moderate yield of 30%. In contrast, N-acylated α-amino acid salts readily gave addition products in fair to high yields of 20–95%. Comparison experiments with N,N-dimethylacetamide and amino-/amido-containing

  涉及N，N-二甲基化α-氨基酸盐和N-甲基邻苯二甲酰亚胺的光反应以光还原和丙酮捕获为主导。仅甘氨酸N-苯基酯以30％的中等收率进行光脱羧。相反，N-酰化的α-氨基酸盐可以很容易地以20-95％的高至中等收率获得加成产物。与N，N-二甲基乙酰胺和含氨基/氨基的邻苯二甲酰亚胺的对比实验揭示了关键的电子转移步骤的起源和反应顺序NR 3  » RCO2个-- ⩾RCONR 2成立。
• Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein
  申请人：Honda Takahiro

  公开号：US20070149574A1

  公开（公告）日：2007-06-28

  A novel cyclic compound having a 4-pyridylalkylthio group having an (un)substituted amino group introduced therein or a salt thereof. They are useful as a medicine. The cyclic compound is a compound represented by the following formula (1), which is useful for the treatment of diseases in which angiogenesis participates. In the following formula (1), ring A represents a benzene ring or a 5- or 6-membered aromatic heterocycle optionally fused with a cycloalkane ring; B represents alkylene; R 1 and R 2 each represents H, (substituted) aryl, (substituted) heterocyclic group, etc.; R 3 and R 4 each represents H, (substituted) alkyl, (substituted) cycloalkyl, -Z-R 5 , etc.; R 5 represents (substituted) alkyl, (substituted) aryl, (substituted) heterocyclic group, etc.; X and Y each represents H, etc.; Z represents —CO—, —COO—, —CONR 6 —, —SO 2 —, etc.; R 6 represents H, etc.; p is 0, 1, or 2; and q is 0 or 1.

  一种具有4-吡啶基烷基硫基团的新型环状化合物，其中引入了（未）取代氨基或其盐。它们可用作药物。环状化合物是由以下式（1）表示的化合物，可用于治疗参与血管生成的疾病。在下式（1）中，环A表示苯环或5-或6-成员芳香杂环，可选择地与环烷环融合；B表示烷基；R1和R2各表示H，（取代）芳基，（取代）杂环基等；R3和R4各表示H，（取代）烷基，（取代）环烷基，-Z-R5等；R5表示（取代）烷基，（取代）芳基，（取代）杂环基等；X和Y各表示H等；Z表示-CO-，-COO-，-CONR6-，-SO2-等；R6表示H等；p为0、1或2；q为0或1。
• NOVEL DERIVATIVES OF PHTHALIMIDE AS HISTONE DEACETYLASE INHIBITORS
  申请人：Gomez Vidal Jose Antonio

  公开号：US20110003878A1

  公开（公告）日：2011-01-06

  The invention relates to novel compounds of general formula (I), or one of the salts thereof, particularly one of the pharmaceutically acceptable salts thereof, or one of the corresponding solvates thereof. These compounds are inhibitors of the histone deacetylase enzymes and are suitable as pharmacologically active agents in a medicament for the treatment and/or prophylaxis of disorders or diseases associated with histone deacetylases. The invention also relates to a process for obtaining the mentioned compounds and the pharmaceutical compositions containing them.

  本发明涉及一般式（I）的新化合物，或其盐之一，特别是其药学上可接受的盐之一，或其相应的溶剂化物之一。这些化合物是组蛋白去乙酰化酶的抑制剂，并且适用于作为药物中的药理活性剂，用于治疗和/或预防与组蛋白去乙酰化酶相关的疾患或疾病。本发明还涉及获得上述化合物的方法和含有它们的制药组合物。
• A Synthetic Strategy for the Preparation of Cyclic Peptide Mimetics Based on SET-Promoted Photocyclization Processes
  作者：Ung Chan Yoon、Ying Xue Jin、Sun Wha Oh、Chan Hyo Park、Jong Hoon Park、Charles F. Campana、Xiaolu Cai、Eileen N. Duesler、Patrick S. Mariano

  DOI：10.1021/ja030297b

  日期：2003.9.1

  A novel method for the synthesis of cyclic peptide analogues has been developed. The general approach relies on the use of SET-promoted photocyclization reactions of peptides that contain N-terminal phthalimides as light absorbing electron acceptor moieties and C-terminal alpha-amidosilane or alpha-amidocarboxylate centers. Prototypical substrates are prepared by coupling preformed peptides with the acid chloride of N-phthalimidoglycine. Irradiation of these substrates results in the generation of cyclic peptide analogues in modest to good yields. The chemical efficiencies of these processes are not significantly affected by (1) the lengths of the peptide chains separating the phthalimide and alpha-amidosilane or alpha-amidocarboxylate centers and (2) the nature of the penultimate cation radical a-heterolytic fragmentation process (i.e., desilylation vs decarboxylation). An evaluation of the effects of N-alkyl substitution on the amide residues in the peptide chain showed that N-alkyl substitution does not have a major impact on the efficiencies of the photocyclization reactions but that it profoundly increases the stability of the cyclic peptide.
• Schapira, Celia B.; Abasolo, Maria I.; Perillo, Isabel A., Journal of Heterocyclic Chemistry, 1985, vol. 22, p. 577 - 581
  作者：Schapira, Celia B.、Abasolo, Maria I.、Perillo, Isabel A.

  DOI：——

  日期：——